$TSOI Therapeutic Solutions International Files Pa
Post# of 12925
Mechanistic Studies Continuing on QuadraMune™ a COVID19 Candidate in Clinical Trial
Company Continues Quest to Dominate Intellectual Property Regarding COVID-19 Associated Pathologies
NEWS PROVIDED BY
Therapeutic Solutions International
Jul 28, 2020, 09:45 ET
https://www.prnewswire.com/news-releases/ther...01258.html